<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Specific Aims (Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="Specific Aims (Phase I): PromptGenix – BioAI Automation Platform."/>
  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{
      max-width: 980px;
      margin: 0 auto;
      padding: 22px 20px 28px;
    }

    .doc-title{
      font-size: 1.28rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 12px 0 4px;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
      margin-bottom: 12px;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin: 14px 0 6px;
    }

    p{
      margin: 0 0 10px;
      font-size: .92rem;
      color:#d1d5db;
    }

    .box{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px solid rgba(148,163,184,0.35);
      background: rgba(15,23,42,0.78);
      margin: 10px 0 12px;
    }
    .box strong{ color:#22c55e; }

    ul{
      margin: 6px 0 0;
      padding-left: 1.08rem;
      font-size: .92rem;
    }
    li{ margin-bottom: 6px; }

    .fine{
      font-size:.78rem;
      color:#9ca3af;
      margin-top: 8px;
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    /* PRINT / PDF (1-page SBIR) */
    @media print {
      @page { size: Letter; margin: 0.5in; }
      header, footer { display: none !important; }

      body{ background:#fff; color:#111; }
      p, li, .meta, .fine{ color:#111 !important; }
      .kicker{ color:#111 !important; }
      .box{ border:1px solid #999; background:#fff; }
      .section{ max-width: 100%; padding: 0; }

      body{ font-size: 96%; line-height: 1.33; }
      li{ margin-bottom: 4px; }

      .box, ul { break-inside: avoid; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html" class="active">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">

      <div class="doc-title">Specific Aims (Phase I): PromptGenix – BioAI Automation Platform</div>
      <div class="meta">
        PromptGenix LLC (Women &amp; Minority-Owned) &middot;
        Contact: dohoon.kim1@icloud.com &middot;
        Website: promptgenix.org/sbir.html
      </div>

      <div class="kicker">Significance</div>
      <p>
        Public immunology and infectious disease research increasingly relies on large-scale RNA-Seq,
        scRNA-Seq, and high-dimensional flow cytometry datasets, yet hypothesis generation remains a
        major bottleneck. Fragmented tools, bespoke scripts, and limited expert time slow analysis,
        reduce reproducibility, and delay experimental decision-making. The critical unmet need is a
        transparent, scalable framework that integrates heterogeneous public evidence into prioritized,
        testable biological hypotheses with quantified uncertainty.
      </p>

      <div class="kicker">Innovation</div>
      <p>
        PromptGenix introduces a <strong>traceable hypothesis intelligence engine</strong> that ranks
        mechanistic hypotheses using statistical evidence modeling and Bayesian updating across public
        omics datasets and literature-derived priors. For each hypothesis <em>H</em>, prior probabilities
        are constructed from pathway relevance, cell-type specificity, and literature support, and are
        updated via likelihood functions derived from observed effect sizes, confidence metrics, and
        cross-dataset consistency to compute posterior confidence scores. Large language models are used
        strictly for interpretability—to explain rankings and cite supporting or conflicting evidence—
        not to determine confidence.
      </p>

      <div class="kicker">Overall objective &amp; central hypothesis</div>
      <div class="box">
        <p style="margin:0;">
          <strong>Objective &amp; Central Hypothesis:</strong>
          This project will deliver a validated Phase I prototype that automatically ingests public
          RNA-Seq and flow cytometry datasets, constructs standardized evidence objects, and outputs
          ranked biological hypotheses with probabilistic confidence, traceable evidence links, and
          recommended validation experiments. We hypothesize that combining deterministic automated
          pipelines with evidence-weighted Bayesian inference and constrained LLM-based interpretability
          will significantly reduce hypothesis generation time while improving transparency,
          reproducibility, and decision quality.
        </p>
      </div>

      <div class="kicker">Specific aims</div>
      <ul>
        <li><strong>Aim 1:</strong> Build deterministic, end-to-end automated RNA-Seq and flow cytometry pipelines using selected public datasets, producing reproducible and versioned evidence outputs.</li>
        <li><strong>Aim 2:</strong> Implement an evidence-weighted hypothesis prioritization engine using statistical scoring and Bayesian updating to compute posterior confidence and rank candidate hypotheses.</li>
        <li><strong>Aim 3:</strong> Generate reviewer-ready HTML/PDF reports and perform pilot usability evaluation demonstrating traceability, uncertainty labeling, and actionable recommendations.</li>
      </ul>

      <div class="kicker">Expected outcomes &amp; deliverables</div>
      <ul>
        <li>A validated prototype producing reproducible evidence objects and ranked hypotheses with posterior confidence estimates.</li>
        <li>Reviewer-ready reports generated within &lt;24 hours for accession-driven runs, with reduced manual synthesis time in pilot feedback.</li>
      </ul>

      <div class="kicker">Impact</div>
      <p style="margin-bottom:0;">
        Phase I will de-risk Phase II development of a scalable hypothesis intelligence platform that
        enables faster, more transparent evidence integration and prioritization for experimental
        planning, supporting—but not replacing—human scientific decision-making.
      </p>

      <div class="fine">
        Phase I SBIR – NIH/NIAID focus &middot; Public-data validation &middot; Women &amp; Minority-Owned Small Business
      </div>

    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal
  </footer>
</div>
</body>
</html>
